AG
GH icon

Aperio Group’s Guardant Health GH Stock Holding History

Aperio Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.31M Buy
10,138
+2,275
+29% +$262K ﹤0.01% 1442
2020
Q3 		$879K Buy
7,863
+2,951
+60% +$270K ﹤0.01% 1502
2020
Q2 		$399K Buy
4,912
+613
+14% +$49.4K ﹤0.01% 1885
2020
Q1 		$299K Buy
+4,299
New +$330K ﹤0.01% 1903

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Aperio Group's GH Position: Q4 2020 in Review

Aperio Group increased its Guardant Health (GH) stake by 29% in Q4 2020, buying an estimated $262K and bringing the position to 10,138 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Aperio Group first reported a position in GH in Q1 2020 and has held it in 4 quarters since. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

  • Aperio Group held 10,138 shares of Guardant Health worth $1.31M as of Q4 2020.
  • Aperio Group bought 2,275 Guardant Health shares in Q4 2020, an estimated $262K.
  • Guardant Health made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1442 holding.
  • Aperio Group first reported a position in Guardant Health in Q1 2020 and has held it in 4 quarters since.
  • 419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.